15271 reports the application procedure for eligible trunk, arm, or leg wounds; Q4150 reports the Allowrap product used with a primary application procedure.
On this page
CMS RVU26D · Effective 2026-10-01
Q4150 Wound matrix Medicare reimbursement rates in Rhode Island
Reports Allowrap DS or Dry supplied for wound coverage, measured by square centimeter and paired with the primary skin-substitute application procedure. Compare Q4150 office and facility rates across CMS payment localities in Rhode Island.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4150 in Rhode Island?
Rhode Island has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$131.46
1 of 1 localities have a supported rate.
Payment area: Rhode Island
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute product
About Q4150: Allowrap wound matrix, per square centimeter
Reports Allowrap DS or Dry supplied for wound coverage, measured by square centimeter and paired with the primary skin-substitute application procedure.
Q4150 identifies Allowrap DS or Dry, a dehydrated amniotic membrane product used as a biologic covering over a prepared wound bed. Wound-care physicians, podiatrists, and surgeons may use it in outpatient or hospital settings for selected wounds, including chronic nonhealing ulcers. The code represents the product, not the clinical work of preparing the wound or applying the material; those services are reported through the applicable procedure code.
Report Q4150 only with a qualifying primary wound-application procedure, such as the appropriate code from the skin-substitute application family. Count the product in square-centimeter units and document the specific product, amount used, wound site and treated area, and the associated application procedure. CMS classifies Q4150 as an add-on and places its payment within the primary procedure’s global period. It is technical-component-only; a separately coded professional interpretation is represented by a separate code.
CMS billing rules for Q4150
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4150 compared with similar codes
Office rates for Rhode Island, from the same CMS release.
15275 reports the application procedure for eligible wounds at other specified sites. Q4150 identifies the product, not the wound-site application service.
Q4151 identifies Amnioband or Guardian, not Allowrap DS or Dry. Select the product code that matches the material supplied.
Q4154 identifies Biovance. Q4150 is specific to Allowrap DS or Dry; the product used determines which supply code applies.
Compare Q4150 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Rhode Island →
Office / nonfacility
$131.46
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4150 in Rhode Island.
PPRRVU2026_Oct_nonQPP.csv
18,243
- Code
- Q4150
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
92
- Locality
- Rhode Island
- Physician work
- 1.019
- Practice expense
- 1.033
- Malpractice
- 0.892
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.019 | 0.0000 |
| Practice expense | 3.81 | × 1.033 | 3.9357 |
| Malpractice | 0.00 | × 0.892 | 0.0000 |
| Total RVUs | 3.9357 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Rhode Island$131.46
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1.019 |
| Practice expense | 3.81 | 1.033 |
| Malpractice | 0 | 0.892 |
(0 × 1.019 + 3.81 × 1.033 + 0 × 0.892) × $33.4009 = $131.46
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4150 billing questions
Can Q4150 be billed by itself?
No. CMS identifies it as an add-on, so report it with the qualifying primary wound-application procedure.
How should units be counted?
The descriptor is based on one square centimeter. Document the quantity of Allowrap supplied for the treated wound area.
Which code reports the application?
Use the primary skin-substitute application procedure appropriate to the wound location and treated area; Q4150 reports the Allowrap product itself.
What does the technical-component classification mean?
CMS classifies Q4150 as technical-component-only. Any separately coded professional interpretation is represented by a separate code.
What documentation supports Q4150?
Record that Allowrap DS or Dry was used, the wound site and treated area, the product quantity, and the paired application procedure.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
